NOVEMBER 3, 2010

Scisive Moderates Session on Top 10 Most Partnerable Drug Candidates

At Windhover's Therapeutic Area Partnerships conference in Boston, MA on November 3, 2010, Scisive Consulting moderated a session on the Top 10 Most Partnerable Drug Candidates in High Value Therapeutic Areas.

The session began with a presentation on Matchmaking in Drug Partnering: Identifying the Right Drugs and the Right Partners which covered:

• Challenges in identifying good science
• Market statistics and market potential
• Competitive landscape
• Where the most promising drug programs are coming from

 
This was followed by a Roundtable Discussion highlighting the top 10 most partnerable drug candidates in the following high value therapeutic areas: Rare diseases, women's health, dermatology, bone and muscle disease, and ophthalmology. The companies presenting were:

• Vital Therapies, Inc.
• Inspire Pharmaceuticals, Inc.
• CoDa Therapeutics, Inc.
• Lithera, Inc.
• Radius Health Inc.
• Osteologix, Inc.
• Lux Biosciences
• Cytokinetics, Inc.
• Anchor Therapeutics
• RXi Pharmaceuticals

Please request a free copy of the Scisive presentation #TAP2010 at This e-mail address is being protected from spambots. You need JavaScript enabled to view it